艾尔维达对过敏性鼻炎的管理:随机对照试验的协议
Shweta Mata1, Shivshankar Rajput1, Isha Preet Tuli2
1Central Ayurveda Research Institute, Central Council for Research in Ayurvedic Sciences, Ministry of Ayush, New Delhi, India.
JMIR research protocols
|September 25, 2024
概括
阿努·泰拉·纳西亚 (Anu Taila Nasya),纳拉迪亚·拉克斯米维拉斯·拉萨 (Naradiya Laxmivilas Rasa) 和希里沙迪·克瓦特 (Shirishadi Kwath) 等阿育吠陀治疗方法显示出对管理过敏性鼻炎 (AR) 的潜力. 这项研究比较了它们对流他鼻喷雾的疗效,建议基于证据的阿育吠陀治疗AR的方法.
科学领域:
- 艾尔韦达医学是一种医药.
- 过敏学 过敏学
- 临床试验中的临床试验.
背景情况:
- 过敏性鼻炎 (AR) 影响全球人口的10-30%,引起像打喷和鼻塞等症状.
- 地理和空气过敏原的变化可能会影响全球AR患病率.
- 目前的管理通常涉及常规治疗,促使对替代疗法的研究.
研究的目的:
- 评估阿育吠陀治疗过敏性鼻炎 (vataja pratishyaya) 的疗效.
- 为了比较Ayurvedic治疗与标准的fluticasone鼻喷雾控制.
- 评估与AR相关的鼻内镜得分和实验室标记的变化.
主要方法:
- 一个开放的,随机对照试验,每组涉及90名参与者,持续24个月.
- 试验组接受了Anu Taila Nasya,Naradiya Laxmivilas Rasa和Shirishadi Kwath. 这三位女性的治疗.
- 对照组接受了流他 propionate 鼻喷雾.
主要成果:
- 截至2024年5月,已注册72名患者,数据分析计划于2025年2月进行.
- 主要结局:控制过敏性鼻炎和喘检测得分的变化.
- 二次结果:鼻腔内镜指数和实验室检测的变化.
结论:
- 艾尔维达治疗显示出作为过敏性鼻炎的基于证据的策略的潜力.
- 进一步的研究和数据分析将巩固这些发现.
- 这项研究有助于理解AR治疗的综合方法.
关键词:
这就是为什么AR AR AR AR.阿努·泰拉·纳西亚 阿努·泰拉·纳西亚纳拉迪亚·拉克什米维拉斯·拉萨·拉萨斯里沙迪·克瓦特 (Shrishadi Kwath) 是一个名为斯里沙迪的女神.过敏性鼻炎 过敏性鼻炎西 propionate 鼻喷雾 鼻喷雾 鼻喷雾随机对照试验是随机对照试验.更多相关视频
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
364
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
364
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245
Drugs Used in Upper Respiratory Disorders: Overview
186
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
186
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
360
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
360


